Anebulo Pharmaceuticals ANEB
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 1.01 | 8 | -22.62 | -2 | -19.87 | 9 |
| 2025Q3 | 2.50 | 10 | -20.17 | -2 | -18.89 | 11 |
| 2025Q2 | 1.44 | 12 | -17.08 | -2 | -16.40 | 12 |
| 2025Q1 | 1.30 | 13 | -11.79 | -2 | -11.23 | 14 |
| 2024Q4 | 1.68 | 15 | -29.22 | -2 | -26.90 | 16 |
| 2024Q3 | 1.93 | 2 | -77.07 | -2 | -67.30 | 2 |
| 2024Q2 | 2.73 | 4 | -30.69 | -1 | -26.81 | 4 |
| 2024Q1 | 2.87 | 5 | -28.84 | -2 | -24.51 | 6 |
| 2023Q4 | 2.42 | 6 | -36.67 | -3 | -32.84 | 8 |
| 2023Q3 | 3.06 | 8 | -26.21 | -2 | -23.95 | 9 |
| 2023Q2 | 2.35 | 11 | -21.20 | -2 | -19.12 | 12 |
| 2023Q1 | 2.90 | 13 | -19.66 | -3 | -17.87 | 14 |
| 2022Q4 | 2.42 | 16 | -22.10 | -4 | -20.85 | 17 |
| 2022Q3 | 2.80 | 19 | -15.28 | -3 | -14.76 | 20 |
| 2022Q2 | 5.20 | 15 | -14.42 | -2 | -14.15 | 16 |
| 2022Q1 | 7.08 | 17 | -10.40 | -2 | -10.36 | 17 |
| 2021Q4 | 6.15 | 19 | -5.53 | -1 | -5.44 | 19 |
| 2021Q3 | 6.55 | 20 | -7.52 | -2 | -7.37 | 21 |
| 2021Q2 | 6.82 | 21 | -29 | -224.42 | 22 | |
| 2021Q1 | -9 | -1 | -16.11 | 4 |